| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927000 | American Heart Journal | 2013 | 8 Pages |
Abstract
The CARMENTA trial investigates whether implementing CTA or CMR early in the diagnostic process in suspected non-ST-elevation MI based on elevated hs-cTnT can prevent unnecessary ICA as compared with routine clinical management, with no detrimental effect on clinical outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martijn W. MD, Bastiaan L.J.H. MD, PhD, Marco MD, PhD, Joachim E. MD, PhD, Harry J.G.M. MD, PhD, Leo F. MD, Hans-Peter MD, PhD, Marja P. PhD, Alma M.A. PhD, Pieter C. PhD, Mark J. MD, PhD, Anton P.M. MD, PhD, Antoinette D.I. PhD, Gaston Vogel, Simon MD,